Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Current Opinion in Endocrinology, Diabetes, and Obesity|July 16, 2021
Survival benefit of endocrine dysfunction following immune checkpoint inhibitors for nonthyroidal cancersAnupam Kotwal, Mabel Ryder
Nature Reviews. Clinical Oncology|March 2, 2016
Evolving molecularly targeted therapies for advanced-stage thyroid cancersKeith C Bible, Mabel Ryder
Thyroid : Official Journal of the American Thyroid Association|December 10, 2019
PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer PatientsAnupam Kotwal, Lisa Kottschade, Mabel Ryder
Endocrine Reviews|July 20, 2019
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and BeyondMaria E Cabanillas, Mabel Ryder, Camilo Jimenez
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2011
A new mechanism for blocking myeloid-derived suppressor cells by CpGMelissa G Lechner, Alan L Epstein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2024
A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid CancerMelissa G Lechner, Gregory A Brent
Journal for Immunotherapy of Cancer|July 2, 2014
Strategies for improving the reporting of human immunophenotypes by flow cytometryMichael P Gustafson, Yi Lin, Mabel Ryder, et al.
Surgical Pathology Clinics|November 2, 2019
Treatment of Differentiated Thyroid CarcinomasMelissa G Lechner, Stephanie Smooke Praw, Trevor E Angell
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2010
Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cellsMelissa G Lechner, Daniel J Liebertz, Alan L Epstein
Pageof 11